Mirae Asset Global Investments Co., Ltd.
Position in CADL — Candel Therapeutics, Inc.
CIK 1569395
SEOUL, M5
Position in CADL
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$18,722
+$3,648 QoQ
Shares Held
3,821
+43.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Mirae Asset Global Investments Co., Ltd. holds $260,099,014 across 207 Biotechnology names. CADL ranks #174 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
188,064 | $83,978,097 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
84,608 | $65,371,524 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
40,926 | $21,423,530 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
56,391 | $18,658,089 | |
| 5 | INSM |
INSMED Inc
|
92,080 | $15,056,920 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
23,740 | $7,050,067 | |
| 7 | RPRX |
Royalty Pharma plc
|
146,024 | $7,004,771 | |
| 8 | INCY |
Incyte Corp
|
47,258 | $4,447,922 |
All Filings in CADL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,722 | 3,821 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $15,074 | 2,668 | Shares | Sole | 2026-01-26 | |
| No filing history on record for this holder in this stock. | ||||||